Does ATEZOLIZUMAB Cause Hepatocellular carcinoma? 342 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 342 reports of Hepatocellular carcinoma have been filed in association with ATEZOLIZUMAB (Tecentriq Hybreza). This represents 1.0% of all adverse event reports for ATEZOLIZUMAB.
342
Reports of Hepatocellular carcinoma with ATEZOLIZUMAB
1.0%
of all ATEZOLIZUMAB reports
191
Deaths
67
Hospitalizations
How Dangerous Is Hepatocellular carcinoma From ATEZOLIZUMAB?
Of the 342 reports, 191 (55.8%) resulted in death, 67 (19.6%) required hospitalization, and 11 (3.2%) were considered life-threatening.
Is Hepatocellular carcinoma Listed in the Official Label?
Yes, Hepatocellular carcinoma is listed as a known adverse reaction in the official FDA drug label for ATEZOLIZUMAB.
What Other Side Effects Does ATEZOLIZUMAB Cause?
Death (3,591)
Off label use (2,340)
Disease progression (1,828)
Pyrexia (1,599)
Diarrhoea (1,490)
Fatigue (1,253)
Anaemia (1,195)
Pneumonia (1,036)
Nausea (953)
Dyspnoea (938)
What Other Drugs Cause Hepatocellular carcinoma?
SORAFENIB (1,665)
RIBAVIRIN (1,046)
SOFOSBUVIR (877)
LEDIPASVIR\SOFOSBUVIR (640)
BEVACIZUMAB (532)
REGORAFENIB (470)
DACLATASVIR (419)
CABOZANTINIB S-MALATE (219)
TACROLIMUS (183)
SOFOSBUVIR\VELPATASVIR (161)
Which ATEZOLIZUMAB Alternatives Have Lower Hepatocellular carcinoma Risk?
ATEZOLIZUMAB vs ATLANTIC SALMON OIL
ATEZOLIZUMAB vs ATOGEPANT
ATEZOLIZUMAB vs ATOMOXETINE
ATEZOLIZUMAB vs ATOMOXETINE\ATOMOXETINE
ATEZOLIZUMAB vs ATORVASTATIN